Thu, February 9, 2012
Wed, February 8, 2012
[ Wed, Feb 08th 2012 ]: Market Wire
Imaging3 Updates Website
Tue, February 7, 2012
Mon, February 6, 2012
Sun, February 5, 2012
[ Sun, Feb 05th 2012 ]: Market Wire
30 a.m. ET
Sat, February 4, 2012
Fri, February 3, 2012
Thu, February 2, 2012
Wed, February 1, 2012
Tue, January 31, 2012
[ Tue, Jan 31st 2012 ]: Market Wire
00 AM EST
Mon, January 30, 2012

SurModics Announces Rescheduled Webcast for First Quarter 2012 Earnings Conference Call on February 6


//health-fitness.news-articles.net/content/2012/ .. 2012-earnings-conference-call-on-february-6.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


EDEN PRAIRIE, Minn.--([ ])--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification technologies to the healthcare industry, announced today that it will be hosting a live webcast of its first quarter 2012 conference call on Monday, February 6, at 9:00 a.m. CT. The Company will issue an earnings news release earlier that morning.

Gary Maharaj, chief executive officer, and Tim Arens, vice president of finance and interim chief financial officer, will recap the first quarter 2012 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Companyas website at [ www.surmodics.com ] the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 12:00 p.m. CT on Monday, February 6, until 12:00 p.m. CT on Monday, February 13 and can be accessed by dialing 800-406-7325 and entering conference call ID passcode 4513088. In addition, the conference call audio will be archived on the Companyas website following the call.

About SurModics, Inc.

SurModicsa vision is to extend and improve the lives of patients through technology innovation. The Company partners with the worldas foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved diagnosis and treatment for patients. Core offerings include: drug delivery technologies (coatings, microparticles, nanoparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit [ www.surmodics.com ]. The content of SurModicsa website is not part of this release or part of any filings the Company makes with the SEC.


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear